Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats

被引:98
作者
Yao, JJ
Bai, SC
Karnauskas, AJ
Bushinsky, DA
Favus, MJ
机构
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[2] Univ Rochester, Sch Med, Rochester, NY USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 05期
关键词
D O I
10.1681/ASN.2004110991
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypercalciuria in inbred genetic hypercalciuric stone-forming (GHS) rats is due, in part, to a decrease in renal tubule Ca reabsorption. Activation of the renal Ca receptor (CaR) may decrease renal tubule Ca reabsorption and cause hypercalciuria through suppression of Ca-sensitive potassium channel activity. Because the. rat renal CaR gene is regulated by extracellular calcium and 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] and GHS rats have increased renal vitamin D receptor content, the current study was undertaken to determine the level of CaR gene expression in GHS rat kidney and whether CaR gene expression is regulated by 1,25(OH)(2)D-3. Male GHS and normal control (NC) rats were fed a Ca-sufficient diet (0.6% Ca). Western blotting revealed a four-fold increase in CaR protein in GHS rat renal tissue, and 1,25(OH)(2)D-3 administration increased renal CaR in both GHS and NC rats. Northern blot analysis of extracts of renal cortical tissue from GHS and NC rats revealed a major 7-kb transcript of CaR and a more modest 4-kb transcript, both of which were readily detectable. Both Northern blotting and real-time reverse transcription-PCR revealed increased basal CaR mRNA expression levels in GHS rat kidney. 1,25(OH)(2)D-3 administration increased renal CaR mRNA levels 2.0- and 3.3-fold in GHS and NC rats, respectively. Despite the greater incremental increase by 1,25(OH)(2)D-3 in NC rats, CaR mRNA levels remained higher in GHS rat kidney, and the elevation was more sustained. 1,25(OH)(2)D-3 increased CaR mRNA through both elevated CaR gene expression and prolonged tissue half-life. These results demonstrate that GHS rats have high levels of CaR gene expression and CaR protein that may contribute to the hypercalciuria and calcium nephrolithiasis.
引用
收藏
页码:1300 / 1308
页数:9
相关论文
共 46 条
[1]   Relationship between supersaturation and crystal inhibition in hypercalciuric rats [J].
Asplin, JR ;
Bushinsky, DA ;
Singharetnam, W ;
Riordon, D ;
Parks, JH ;
Coe, FL .
KIDNEY INTERNATIONAL, 1997, 51 (03) :640-645
[2]   STUDY OF CALCIUM ABSORPTION IN MAN - A KINETIC ANALYSIS AND PHYSIOLOGIC MODEL [J].
BIRGE, SJ ;
PECK, WA ;
BERMAN, M ;
WHEDON, GD .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (09) :1705-&
[3]   EVIDENCE FOR DISORDERED CONTROL OF 1,25-DIHYDROXYVITAMIN-D PRODUCTION IN ABSORPTIVE HYPERCALCIURIA [J].
BROADUS, AE ;
INSOGNA, KL ;
LANG, R ;
ELLISON, AF ;
DREYER, BE .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (02) :73-80
[4]   Rat calcium-sensing receptor is regulated by vitamin D but not by calcium [J].
Brown, AJ ;
Zhong, M ;
Finch, J ;
Ritter, C ;
McCracken, R ;
Morrissey, J ;
Slatopolsky, E .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 270 (03) :F454-F460
[5]   Extracellular calcium sensing and extracellular calcium signaling [J].
Brown, EM ;
MacLeod, RJ .
PHYSIOLOGICAL REVIEWS, 2001, 81 (01) :239-297
[6]   Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats [J].
Bushinsky, DA ;
Neumann, KJ ;
Asplin, J ;
Krieger, NS .
KIDNEY INTERNATIONAL, 1999, 55 (01) :234-243
[7]   INCREASED URINARY SATURATION AND KIDNEY CALCIUM CONTENT IN GENETIC HYPERCALCIURIC RATS [J].
BUSHINSKY, DA ;
KIM, M ;
SESSLER, NE ;
NAKAGAWA, Y ;
COE, FL .
KIDNEY INTERNATIONAL, 1994, 45 (01) :58-65
[8]   Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats [J].
Bushinsky, DA ;
Asplin, JR ;
Grynpas, MD ;
Evan, AP ;
Parker, WR ;
Alexander, KM ;
Coe, FL .
KIDNEY INTERNATIONAL, 2002, 61 (03) :975-987
[9]   Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats [J].
Bushinsky, DA ;
Grynpas, MD ;
Asplin, JR .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1415-1423
[10]  
Bushinsky DA, 2000, KIDNEY INT, V57, P550